Evidence map›Paper›PMID 31417276›Full record

ArticleOncoTargets and therapy2019

Decreased expression of SPINT1-AS1 and SPINT1 mRNA might be independent unfavorable prognostic indicators in esophageal squamous cell carcinoma.

Fang-Fang Shen, Ying Pan, Hai-Jun Yang, Jun-Kuo Li, Fang Zhao, Jing-Fen Su, Yan-Yan Li, Lin-Qiang Tian, Pan-Ting Yu, Yan-Tian Cao and 2 more

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Disulfidptosis in tumor progression.Cell death discovery · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. LowJournal of Cancer · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Fang-Fang Shen *The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Ying Pan *The Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Hai-Jun YangAnyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang, Henan, People's Republic of China.
Jun-Kuo LiAnyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang, Henan, People's Republic of China.
Fang ZhaoAnyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang, Henan, People's Republic of China.
Jing-Fen SuAnyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang, Henan, People's Republic of China.
Yan-Yan LiThe Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Lin-Qiang TianThe Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Pan-Ting YuThe Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Yan-Tian CaoThe Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Yao-Wen ZhangAnyang Key Laboratory for Esophageal Cancer Research, Anyang Tumor Hospital, Anyang, Henan, People's Republic of China.
Fu-You ZhouThe Key Laboratory for Tumor Translational Medicine, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, People's Republic of China.
Xinxiang Medical University · CNAnyang Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

esophageal squamous cell carcinomaprognosisSPINT1SPINT1-AS1

Identifiers

PMID31417276
PMCPMC6591775
OpenAlexW2951119269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.